BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12222838)

  • 21. Overexpressed TP73 induces apoptosis in medulloblastoma.
    Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
    BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [An immunohistochemical study of tenascin expression in cerebellar medulloblastomas].
    Korshunov AG; Golanov AV; Sycheva RV
    Zh Vopr Neirokhir Im N N Burdenko; 1997; (4):23-7. PubMed ID: 9460893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased p53 immunopositivity in anaplastic medulloblastoma and supratentorial PNET is not caused by JC virus.
    Eberhart CG; Chaudhry A; Daniel RW; Khaki L; Shah KV; Gravitt PE
    BMC Cancer; 2005 Feb; 5():19. PubMed ID: 15717928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.
    Leonard JR; Cai DX; Rivet DJ; Kaufman BA; Park TS; Levy BK; Perry A
    J Neurosurg; 2001 Jul; 95(1):82-8. PubMed ID: 11453402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence in medulloblastoma - influence of clinical, histological and immunohistochemical factors.
    Srikantha U; Balasubramaniam A; Santosh V; Somanna S; Bhagavatula ID; Ashwathnarayana CB
    Br J Neurosurg; 2010 Jun; 24(3):280-8. PubMed ID: 20465457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased height in patients with medulloblastomas.
    Robertson SC; Ackerman LL; Traynelis VC; Menezes AH
    Neurosurgery; 1997 Sep; 41(3):561-5; discussion 565-6. PubMed ID: 9310972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Medulloblastomas: clinical, epidemiological and pathological findings in 28 cases].
    Reis Filho JS; Gasparetto EL; Faoro LN; Araújo JC; Torres LF
    Arq Neuropsiquiatr; 2000 Mar; 58(1):76-80. PubMed ID: 10770870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic markers in paediatric medulloblastoma: a Paediatric Oncology Group Study.
    McLendon RE; Friedman HS; Fuchs HE; Kun LE; Bigner SH
    Histopathology; 1999 Feb; 34(2):154-62. PubMed ID: 10064395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medulloblastoma: evaluation of proliferative index by monoclonal antibody Mib-1, its prognostic correlation and therapeutic implications.
    Ferrari AF; Araújo MB; Aguiar PH; Plese JP
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):547-51. PubMed ID: 14513155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical analysis for histopathological subtypes in pediatric medulloblastomas.
    Son EI; Kim IM; Kim DW; Yim MB; Kang YN; Lee SS; Kwon KY; Suh SI; Kwon TK; Lee JJ; Kim DS; Kim SP
    Pathol Int; 2003 Feb; 53(2):67-73. PubMed ID: 12588433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor cell proliferation and apoptosis in medulloblastoma.
    Schiffer D; Cavalla P; Chiò A; Giordana MT; Marino S; Mauro A; Migheli A
    Acta Neuropathol; 1994; 87(4):362-70. PubMed ID: 7912469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptosis and cell proliferation in human neuroepithelial tumors.
    Schiffer D; Cavalla P; Migheli A; Chiò A; Giordana MT; Marino S; Attanasio A
    Neurosci Lett; 1995 Aug; 195(2):81-4. PubMed ID: 7478273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebellar medulloblastomas: a study of 35 cases with particular reference to cellular differentiation.
    Kasantikul V; Shuangshoti S
    Surg Neurol; 1986 Dec; 26(6):532-41. PubMed ID: 3775629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medulloblastoma: survey of factors possibly influencing the prognosis.
    Müller W; Afra D; Schröder R; Slowik F; Wilcke O; Klug N
    Acta Neurochir (Wien); 1982; 64(3-4):215-24. PubMed ID: 7136866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebellar desmoplastic medulloblastomas. A further immunohistochemical characterization of the reticulin-free pale islands.
    Katsetos CD; Herman MM; Frankfurter A; Gass P; Collins VP; Walker CC; Rosemberg S; Barnard RO; Rubinstein LJ
    Arch Pathol Lab Med; 1989 Sep; 113(9):1019-29. PubMed ID: 2505732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric medulloblastoma: prognostic value of p53, bcl-2, Mib-1, and microvessel density.
    Miralbell R; Tolnay M; Bieri S; Probst A; Sappino AP; Berchtold W; Pepper MS; Pizzolato G
    J Neurooncol; 1999; 45(2):103-10. PubMed ID: 10778725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factor I receptor activity in human medulloblastomas.
    Del Valle L; Enam S; Lassak A; Wang JY; Croul S; Khalili K; Reiss K
    Clin Cancer Res; 2002 Jun; 8(6):1822-30. PubMed ID: 12060623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med.
    Katsetos CD; Herman MM; Krishna L; Vender JR; Vinores SA; Agamanolis DP; Schiffer D; Burger PC; Urich H
    Arch Pathol Lab Med; 1995 Aug; 119(8):734-43. PubMed ID: 7646332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell kinetics of medulloblastomas.
    Ito S; Hoshino T; Prados MD; Edwards MS
    Cancer; 1992 Aug; 70(3):671-8. PubMed ID: 1623482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of KBTBD4 Mutations in Molecularly Classified Brazilian Medulloblastomas.
    Leal LF; Cavagna RO; Campanella NC; Mançano B; Almeida GC; Matsushita M; Almeida Junior CR; Saggioro F; Stavale JN; Malheiros SMF; Lima M; Hajj GNM; Neder L; Reis RM
    J Neuropathol Exp Neurol; 2019 Sep; 78(9):788-790. PubMed ID: 31403685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.